Published on 5 Dec 2023 on Simply Wall St. via Yahoo Finance
With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional...
Key Insights
Significantly high institutional ownership implies Black Diamond Therapeutics' stock price is sensitive to their trading actions53% of the business is held by the top 6 shareholdersOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
A look at the shareholders of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) can tell us which group is most powerful. With 58% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).